Skip to main content

Table 3 Vital signs after autologous E.coli autovaccine application

From: Safety, tolerability, and impact on allergic inflammation of autologous E.coli autovaccine in the treatment of house dust mite asthma - a prospective open clinical trial

  Heartbeat/min. Body temperature [°C]
  0' 30' 60' 90' 120' 0' 30' 60' 90' 120'
Subject No. 1
median 75.0 72.0 74.0 75.0 72.0 36.4 36.2 36.2 36.4 36.4
SD 6.03 6.55 5.31 5.15 5.27 0.68 0.69 0.64 0.62 0.57
Subject No. 2
median 86.0 83.5 83.0 80.0 77.5 36.8 37.0 37.0 36.9 36.8
SD 6.55 12.2 11.2 12.5 9.72 0.32 0.309 0.207 0.2 0.19
Subject No. 3
median 64.0 64.0 62.0 58.0 59.0 36.2 36.3 36.3 36.4 36.2
SD 8.88 5.4 5.60 8.16 5.66 0.34 0.30 0.31 0.38 0.27
Subject No. 4
median 64 80 78.5 80 78 36.4 36.5 36.7 36.6 36.7
SD 16.0 12.5 13.2 7.8 8.48 0.29 0.37 0.54 0.33 0.29
Subject No. 5
median 76 69.5 70.5 69.0 66.0 36.2 36.3 36.2 36.4 36.3
SD 10.2 12.6 11.7 11.8 7.87 0.20 0.30 0.19 0.26 0.16
Subject No. 6
median 79.0 76.0 74.5 74.0 73.5 36.2 36.20 36.2 36.3 36.3
SD 11.0 7.94 5.82 4.63 5.17 0.22 0.26 0.30 0.27 0.31
Subject No. 7
median 75.0 75.0 68.5 74.5 73.0 36.4 36.2 36.2 36.1 36.2
SD 4.90 5.97 7.87 5.72 5.43 0.33 0.29 0.29 0.21 0.37
Subject No. 8
median 80 80 80 79.5 80 36.1 36.1 36.1 36.1 36.1
SD 6.35 6.16 6.65 7.23 5.81 0.05 0.05 0.05 0.04 0.05
Subject No. 9
median 72 68 68 68 68 36.1 36.1 36.1 36.1 36.1
SD 9.70 10.1 9.51 8.35 8.51 0.05 0.05 0.06 0.04 0.04
  1. SD = standard deviation